Net Income (TTM) Chart

View Net Income (TTM) for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -37.84M
March 31, 2026 -40.18M
December 31, 2025 -39.57M
September 30, 2025 -45.86M
June 30, 2025 -54.61M
March 31, 2025 -51.28M
December 31, 2024 -51.90M
September 30, 2024 -46.84M
June 30, 2024 -38.66M
March 31, 2024 -38.99M
December 31, 2023 -35.20M
September 30, 2023 -32.90M
Date Value
June 30, 2023 -29.44M
March 31, 2023 -29.18M
December 31, 2022 -35.39M
September 30, 2022 -13.85M
June 30, 2022 -22.35M
March 31, 2022 -32.13M
December 31, 2021 -54.57M
September 30, 2021 -98.34M
June 30, 2021 -100.30M
March 31, 2021 -103.57M
December 31, 2020 -80.11M
September 30, 2020 -67.25M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Precigen, Inc. -157.70M
Agenus, Inc. 91.94M
Amgen, Inc. 8.743B
Anika Therapeutics, Inc. -3.121M
BioCryst Pharmaceuticals, Inc. -384.67M